Natural killer (NK) cells participate in the innate immune response against pathogens and tumors. There is growing evidence that they are involved in allograft rejection and possibly in certain autoimmune diseases. The receptors on NK cells responsible for their activation are only now being appreciated. One of these receptors, NKG2D has been implicated in the ability of NK cells to kill certain tumors and virus-infected cells. NKG2D is present on all NK cells, CDS+T cells, y6-TcR + T cells and some activated macrophages. Recently, we and others cloned a family of mouse genes, designated RAE-1, encoding MHC class I-like proteins that bind with high affinity to mouse NKG2D. Human orthologs of the RAE-1 genes (designated as either ULBP or RAE-l-like genes) have been identified and the proteins encoded by these genes are recognized by the human NKG2D receptor. In humans, the NKG2D receptor also recognizes MICA and MICB, polymorphic MHC class I antigens that are induced by stress, transformation and viral infection. Emerging evidence suggests that the RAE-1 and MIC glycoproteins may serve to trigger the innate immune responses mediated by NK cells and yS-TcR +T cells and function to co-stimulate antigen-specific responses by CD8 + cytotoxic T lymphocytes. We propose to investigate the RAE-I family of genes and determine their role in innate and adaptive immune responses.
The specific aims of this program are: 1) to determine whether the RAE-1 genes are polymorphic, analyze their expression and determine if they elicit allogeneic responses, 2) to establish the relevance of induction of the RAE-1 molecules during viral infection, to determine how the human CMV UL 16 protein and potentially other viral proteins interfere with RAE-1, and to evaluate whether viruses other than HCMV induce the RAE-1 genes, and 3) to evaluate the mechanisms responsible for the induction of the RAE-1 genes in normal cells. The overall objective of this project is to understand both the beneficial and potentially adverse functions of the RAE- 1 family of antigens in innate and adaptive immune responses.
| Morvan, Maelig G; Champsaur, Marine; Reizis, Boris et al. (2017) Chronic In Vivo Interaction of Dendritic Cells Expressing the Ligand Rae-1? with NK Cells Impacts NKG2D Expression and Function. Immunohorizons 1:10-19 |
| Weinger, Jason G; Plaisted, Warren C; Maciejewski, Sonia M et al. (2014) Activating receptor NKG2D targets RAE-1-expressing allogeneic neural precursor cells in a viral model of multiple sclerosis. Stem Cells 32:2690-701 |
| Beaulieu, Aimee M; Bezman, Natalie A; Lee, Jang Eun et al. (2013) MicroRNA function in NK-cell biology. Immunol Rev 253:40-52 |
| Lanier, Lewis L (2013) Shades of grey--the blurring view of innate and adaptive immunity. Nat Rev Immunol 13:73-4 |
| Kim, Charles C; Lanier, Lewis L (2013) Beyond the transcriptome: completion of act one of the Immunological Genome Project. Curr Opin Immunol 25:593-7 |
| Min-Oo, Gundula; Kamimura, Yosuke; Hendricks, Deborah W et al. (2013) Natural killer cells: walking three paths down memory lane. Trends Immunol 34:251-8 |
| Benoist, Christophe; Lanier, Lewis; Merad, Miriam et al. (2012) Consortium biology in immunology: the perspective from the Immunological Genome Project. Nat Rev Immunol 12:734-40 |
| Orr, Mark T; Lanier, Lewis L (2011) Inhibitory Ly49 receptors on mouse natural killer cells. Curr Top Microbiol Immunol 350:67-87 |
| Sun, Joseph C; Lopez-Verges, Sandra; Kim, Charles C et al. (2011) NK cells and immune ""memory"". J Immunol 186:1891-7 |
| Orr, Mark T; Lanier, Lewis L (2011) Natural killer cell licensing during viral infection. Adv Exp Med Biol 780:37-44 |
Showing the most recent 10 out of 44 publications
